Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • gw501516 cas 317318-70-0

12 月 . 13, 2024 15:52 Back to list

gw501516 cas 317318-70-0



Exploring GW501516 The Science Behind the Compound


GW501516, also known by its CAS number 317318-70-0, is a synthetic compound that has garnered attention in both the scientific community and the realm of fitness and bodybuilding. Originally developed in the late 1990s by researchers at GlaxoSmithKline, GW501516 is primarily recognized as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It was designed to potentially treat metabolic and cardiovascular diseases due to its influence on lipid metabolism and mitochondrial function.


Exploring GW501516 The Science Behind the Compound

Research has indicated that GW501516 can improve exercise capacity by stimulating the production of mitochondria in muscle cells. Mitochondria are the powerhouses of the cell, responsible for generating energy. With increased mitochondrial biogenesis, users may experience enhanced stamina and reduced fatigue during prolonged physical activities. This potential has led to discussions regarding its use as a performance-enhancing agent among athletes, particularly in endurance sports such as cycling and running.


gw501516 cas 317318-70-0

gw501516 cas 317318-70-0

However, despite its promising properties, the use of GW501516 is not without controversy. In 2007, it was included on the list of banned substances by the World Anti-Doping Agency (WADA) due to its potential misuse in sports for performance enhancement. The association with doping has overshadowed much of the research focused on its therapeutic potential for metabolic diseases. Additionally, while animal studies have displayed positive results regarding fat loss and endurance, human studies remain limited, and the long-term effects of GW501516 are not fully understood.


Another important aspect to consider is the side effect profile of GW501516. Clinical trials have raised concerns over its safety as certain studies have indicated a potential link to cancer development in animal models. While these findings do not directly translate to humans, they underline the necessity of cautious interpretation of GW501516's effects and the importance of rigorous clinical evaluations before it can be deemed safe for long-term human use.


In conclusion, GW501516 (CAS 317318-70-0) represents a fascinating intersection of metabolic research and sports performance enhancement. Its ability to activate PPARδ and potentially improve endurance and fat metabolism has captured the interest of both scientists and athletes. However, the concerns regarding its safety, legality in sports, and ethical implications of its use necessitate a comprehensive approach to research and dialogue on the compound. As we continue to explore the biochemical pathways through which GW501516 operates, it is crucial to balance innovation with safety, ensuring that compounds with such strong biological effects are thoroughly assessed before widespread application.


As the interest in GW501516 continues to develop, ongoing research is essential to unlock its true potential and clarify its role in both therapeutic and athletic settings. The journey of GW501516 is a reminder of the complexities involved in drug development and the fine line between scientific advancement and ethical responsibility.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
zh_TWChina (Taiwan)
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu zh_TWChina (Taiwan)